NLRP3 and metabolic dysfunction-associated steatotic liver disease: Interestingly, activation of the NLRP3 inflammasome complex has also been described in insulin-sensitive tissues, for instance, in white adipose tissue and the liver [31,32], promoting the pro-inflammatory processes associated with metabolic disorders, such as insulin resistance, and other related illnesses, such as nonalcoholic fatty liver disease [33].